Skip to content

Models 4000, 4900, 6000, 8000, 8900, Luxus 6&100/1700 - 8900

by Heraeus Lasersonics, Inc.

510(k) K904444

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK904444 Date13 Dec 1990ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GEX
Models / Variants
8900
Device Class
Class II
Regulation
21 CFR Part 878.4810
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Models 4000, 4900, 6000, 8000, 8900, and Luxus 6&100/1700 are powered laser surgical instruments designed for use in general and plastic surgery procedures. These devices utilize Nd:YAG and CO₂ laser technologies to deliver precise, controlled energy for tissue ablation, coagulation, or vaporization in surgical applications.

These instruments are supplied as reusable medical devices and are intended for use in clinical settings where sterile conditions are maintained. They are classified under the GEX product code and have received FDA 510(k) clearance under the Traditional 510(k) review pathway. Each model number and reference code (e.g., 4000, 6&100/1700) corresponds to specific laser parameters and configurations, as detailed in the original specifications.

Other devices from Heraeus Lasersonics, Inc.

See all devices from Heraeus Lasersonics, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these laser surgical instruments designed for single-use or can they be reused in a clinical setting?

    These instruments are reusable medical devices, meaning they are intended to be cleaned, sterilized, and reused multiple times in clinical settings where sterile conditions are maintained. Since they are classified as reusable, proper maintenance and sterilization protocols must be followed as outlined in the manufacturer’s instructions to ensure safety and performance.

  • What types of surgical procedures are these laser devices primarily used for?

    These devices are powered laser surgical instruments designed for use in general and plastic surgery procedures. They utilize Nd:YAG and CO₂ laser technologies to perform precise tissue ablation, coagulation, or vaporization, making them suitable for procedures requiring controlled energy delivery in surgical environments.

  • How do I determine which model is best suited for my specific surgical needs?

    Each model (e.g., 4000, 6000, Luxus 6&100/1700) corresponds to specific laser parameters and configurations, including wavelength, power output, and beam characteristics. The manufacturer’s documentation provides detailed specifications for each model, allowing you to select the one that aligns with your intended surgical application—whether for tissue ablation, coagulation, or vaporization in general or plastic surgery.

  • What regulatory pathway was followed for FDA clearance of these devices?

    These devices received FDA 510(k) clearance under the Traditional 510(k) review pathway, meaning they were determined to be substantially equivalent to a legally marketed predicate device. The clearance was granted under the General, Plastic Surgery advisory committee (SU) and assigned the product code GEX. The submission was filed in 1990 and received a decision in December of the same year.